| Reference | 1: Tashtoush BM, Qasem J, Williams JD, DeWald TP, Jacobson EL, Jacobson MK.
Analysis and stability study of myristyl nicotinate in dermatological
preparations by high-performance liquid chromatography. J Pharm Biomed Anal. 2007
Feb 19;43(3):893-9. Epub 2006 Oct 16. PubMed PMID: 17049429.
<br>
2: Tashtoush BM, Kim H, Jacobson EL, Jacobson MK. Formulation compatibility of
myristyl nicotinate with drugs used to treat dermatological conditions involving
an impaired skin barrier. Drug Dev Ind Pharm. 2007 Nov;33(11):1176-82. PubMed
PMID: 18058313.
<br>
3: Jacobson MK, Kim H, Coyle WR, Kim M, Coyle DL, Rizer RL, Jacobson EL. Effect
of myristyl nicotinate on retinoic acid therapy for facial photodamage. Exp
Dermatol. 2007 Nov;16(11):927-35. PubMed PMID: 17927576.
<br>
4: Catz P, Shinn W, Kapetanovic IM, Kim H, Kim M, Jacobson EL, Jacobson MK, Green
CE. Simultaneous determination of myristyl nicotinate, nicotinic acid, and
nicotinamide in rabbit plasma by liquid chromatography-tandem mass spectrometry
using methyl ethyl ketone as a deproteinization solvent. J Chromatogr B Analyt
Technol Biomed Life Sci. 2005 Dec 27;829(1-2):123-35. Epub 2005 Nov 7. PubMed
PMID: 16275131.
<br>
5: Tashtoush BM, Bennamani AN, Al-Taani BM. Preparation and characterization of
microemulsion formulations of nicotinic acid and its prodrugs for transdermal
delivery. Pharm Dev Technol. 2013 Jul-Aug;18(4):834-43. doi:
10.3109/10837450.2012.727003. Epub 2012 Oct 3. PubMed PMID: 23030413.
<br>
6: Jacobson EL, Kim H, Kim M, Williams JD, Coyle DL, Coyle WR, Grove G, Rizer RL,
Stratton MS, Jacobson MK. A topical lipophilic niacin derivative increases NAD,
epidermal differentiation and barrier function in photodamaged skin. Exp
Dermatol. 2007 Jun;16(6):490-9. PubMed PMID: 17518989.
<br>
7: Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp
Clin Pharmacol. 2007 Oct;29(8):547-83. PubMed PMID: 18040531.
|
